fbpx
May 31, 2023

Stem Cell Transplant More Effective Than Some MS Therapies Stem Cell Transplant More Effective Than Some MS Therapies

Autologous hematopoietic stem cell transplant (AHSCT) is more effective than fingolimod and natalizumab for patients with highly active relapsing-remitting multiple sclerosis (MS), data indicate. In a […]
May 31, 2023

Troponin to ID Diabetes Patients With Silent Heart Disease? Troponin to ID Diabetes Patients With Silent Heart Disease?

Nearly 1 in 5 US adults with type 2 diabetes but without symptoms of cardiovascular disease (CVD) have a clinically meaningful elevation of a marker of […]
May 31, 2023

Using ‘Green’ Buses Could Up School Attendance Using ‘Green’ Buses Could Up School Attendance

Switching to greener, cleaner, and more reliable buses may cut down on student absences, according to researchers in epidemiology at the University of Michigan using data […]
May 31, 2023

Enthesitis Linked to Dupilumab Use for Atopic Dermatitis Enthesitis Linked to Dupilumab Use for Atopic Dermatitis

Around 5% of patients treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis experience musculoskeletal (MSK) symptoms, according to the results of a descriptive study. The main […]
May 31, 2023

Posluma Approved for PET Imaging in Prostate Cancer Posluma Approved for PET Imaging in Prostate Cancer

The US Food and Drug Administration (FDA) has approved flotufolastat fluorine-18 (Posluma), a radiopharmaceutical for use with positron-emission tomography (PET) in prostate cancer. The product is […]
May 31, 2023

Endoscopists Outperform CADx in Predicting Polyp Histology Endoscopists Outperform CADx in Predicting Polyp Histology

Endoscopists’ predictions of polyp histology were more accurate than those of a computer-aided diagnostic tool (CADx) in real-time colonoscopy, but overall accuracy was highest when the endoscopists […]
May 30, 2023

Internists: Increased earnings can’t stop rising discontent Internists: Increased earnings can’t stop rising discontent

Internists experienced many of the usual ups and downs regarding nonclinical matters in 2022: Compensation was up, but satisfaction with compensation was down; the percentage of […]
May 30, 2023

No Signal of Higher Noncardiac Death With Revascularization No Signal of Higher Noncardiac Death With Revascularization

In response to a randomized trial that associated elective revascularization for ischemia with an increase in noncardiac mortality versus medical therapy alone, a meta-analysis with a […]
May 30, 2023

Tenecteplase Late After Stroke Misses Endpoint: TIMELESS Tenecteplase Late After Stroke Misses Endpoint: TIMELESS

Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial. However, there were some […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0